Your session is about to expire
What is Azasite
AzithromycinThe Generic name of this drug
Treatment SummaryAzithromycin is an antibiotic used to treat bacterial infections, such as respiratory, enteric, and genitourinary infections. It belongs to the azalide class of macrolides, which have a 15-membered ring and a methyl-substituted nitrogen instead of a carbonyl group at the 9a position on the aglycone ring. This prevents its metabolism, making it more effective than other macrolide antibiotics. In 2020, a study was conducted to investigate the use of azithromycin in combination with hydroxychloroquine to treat COVID-19, with positive results. However
Zithromaxis the brand name
Azasite Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Zithromax
Azithromycin
1994
541
Approved as Treatment by the FDA
Azithromycin, otherwise called Zithromax, is approved by the FDA for 27 uses including Streptococcal Pharyngitis and Community Acquired Pneumonia (CAP) .Streptococcal Pharyngitis
Community Acquired Pneumonia (CAP)
Haemophilus Influenzae Infections
Adult Patients
ABDIC protocol
Genus Chlamydia
patients appropriate for oral therapy
Adults
Moraxella Catarrhalis Infection
Communicable Diseases
Staphylococcus (S.) Aureus Infection
Sinusitis
Tonsillitis
Genital Ulcer Disease (GUD)
genital ulcers caused by haemophilus ducreyi infection
Haemophilus ducreyi infection
Moraxella catarrhalis
unable to prescribe first line therapy for streptococcus pyogenes tonsillitis
Pneumococcal Infections
Streptococcus pyogenes
Pneumonia, Mycoplasma
Tonsillitis
Pediatric Patients
Otitis
Sore Throat
Streptococcus pyogenes
Streptococcus Agalactiae Infection
Effectiveness
How Azasite Affects PatientsMacrolides are antibiotics that work by stopping the bacteria from making proteins, which helps to treat bacterial infections. Azithromycin has been used to treat chronic inflammatory respiratory diseases, as it also helps to regulate the immune system.
How Azasite works in the bodyAzithromycin is an antibiotic used to treat bacterial infections. It works by preventing bacteria from producing proteins they need to survive. Specifically, it binds to the ribosome and stops it from being able to make proteins. This makes it effective against a wide range of bacteria. Azithromycin is also very stable at a low pH, meaning it stays in the body longer and can build up to higher levels in tissue than other antibiotics.
When to interrupt dosage
The prescribed measure of Azasite is contingent upon the recognized sickness, including Streptococcus Agalactiae Infection, Chlamydia trachomatis and Genus Chlamydia. The magnitude of dosage is contingent upon the technique of delivery, as detailed in the table beneath.Condition
Dosage
Administration
Streptococcus pyogenes
, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL
, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral
Sinusitis
, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL
, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral
Community Acquired Pneumonia (CAP)
, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL
, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral
Streptococcus Agalactiae Infection
, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL
, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral
Moraxella catarrhalis
, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL
, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral
patients appropriate for oral therapy
, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL
, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral
Pneumonia, Mycoplasma
, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL
, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral
Urethritis
, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL
, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral
Tonsillitis
, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL
, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral
Bacterial conjunctivitis
, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL
, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral
Communicable Diseases
, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL
, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral
Bacterial Conjunctivitis
, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL
, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral
Streptococcus pyogenes
, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL
, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral
Communicable Diseases
, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL
, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral
Pediatric Patients
, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL
, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral
Genus Chlamydia
, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL
, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral
Genital Ulcer Disease (GUD)
, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL
, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral
Haemophilus ducreyi infection
, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL
, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral
unable to prescribe first line therapy for streptococcus pyogenes tonsillitis
, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL
, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral
Staphylococcus (S.) Aureus Infection
, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL
, Oral, Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Tablet, Tablet - Oral, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release, Granule, for suspension, extended release - Oral, Solution, Solution - Ophthalmic, For suspension, For suspension - Oral, Parenteral, Powder, for suspension - Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral
Warnings
Azasite ContraindicationsCondition
Risk Level
Notes
Jaundice, Obstructive
Do Not Combine
prior azithromycin use
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Azithromycin may interact with Pulse Frequency
Severe Hypersensitivity Reactions
Do Not Combine
Azithromycin may interact with Pulse Frequency
Severe Hypersensitivity Reactions
Do Not Combine
Azithromycin may interact with Pulse Frequency
Severe Hypersensitivity Reactions
Do Not Combine
Azithromycin may interact with Pulse Frequency
Common Azasite Drug Interactions
Drug Name
Risk Level
Description
Anagrelide
Major
The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Anagrelide.
Arsenic trioxide
Major
The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Arsenic trioxide.
Artemether
Major
The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Artemether.
Asenapine
Major
The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Asenapine.
Astemizole
Major
The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Astemizole.
Azasite Toxicity & Overdose RiskAzithromycin has been found to be toxic to rats when taken orally at a dose of >2000mg/kg. Possible side effects include irregular heartbeats, hearing loss, decreased effectiveness of the drug, and rare cases of liver or kidney damage. Pregnant women should only take azithromycin if absolutely necessary, as the effects on the fetus are unknown. Nursing mothers should take caution when taking azithromycin, as it is not known if the drug is excreted in human milk. No long-term studies have been done to determine if the drug is carcinogenic or has any effects on fertility
Azasite Novel Uses: Which Conditions Have a Clinical Trial Featuring Azasite?
Currently, 9 active clinical trials are investigating the potential of Azasite to treat Moraxella Catarrhalis Infection, Staphylococcus (S.) Aureus Infection and other Communicable Diseases.Condition
Clinical Trials
Trial Phases
Cervicitis
0 Actively Recruiting
Sinusitis
0 Actively Recruiting
Communicable Diseases
0 Actively Recruiting
Bacterial Conjunctivitis
0 Actively Recruiting
Moraxella catarrhalis
0 Actively Recruiting
Genital Ulcer Disease (GUD)
0 Actively Recruiting
Haemophilus Influenzae Infections
0 Actively Recruiting
Bacterial conjunctivitis
0 Actively Recruiting
Diarrhea
0 Actively Recruiting
Streptococcus pyogenes
0 Actively Recruiting
Tonsillitis
0 Actively Recruiting
Communicable Diseases
3 Actively Recruiting
Phase 2, Not Applicable
Pneumococcal Infections
5 Actively Recruiting
Phase 2, Phase 3, Phase 1
Pediatric Patients
0 Actively Recruiting
Adult Patients
0 Actively Recruiting
unable to prescribe first line therapy for streptococcus pyogenes tonsillitis
0 Actively Recruiting
Streptococcus pyogenes
0 Actively Recruiting
Streptococcus Agalactiae Infection
0 Actively Recruiting
Staphylococcus (S.) Aureus Infection
1 Actively Recruiting
Phase 4
Chancroid
0 Actively Recruiting
Azasite Reviews: What are patients saying about Azasite?
1.7Patient Review
1/10/2013 The packaging is really inconvenient, and you don't get enough drops to finish the treatment.
1.3Patient Review
2/20/2012 Terrible. It was very expensive and hard to dispense and burns like hell. The other opthalmic solutions I've used for pink eye have been completely painless and effective. My doc told me this was better. Not so, my eyes still hurt 1 hour after putting these slimy drops in.
1.3Patient Review
4/10/2012 Not only is this medication overpriced, but one container does not have enough product to finish the recommended course of treatment. In addition, this drug did nothing to ease my symptoms.
1Patient Review
2/13/2012Patient Q&A Section about azasite
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.Is AzaSite still available?
"There is no version of Azasite that is equivalent to the therapeutic version available in the United States. These online pharmacies selling the generic version may be counterfeit and potentially unsafe."
Answered by AI
What kind of drug is AzaSite?
"Azasite is a semi-synthetic macrolide antibiotic used for the bacterial conjunctivitis."
Answered by AI
What is AzaSite used to treat?
"It will not work for other types of eye infections.
This medication is used to treat certain eye infections which are caused by bacteria. It works by stopping the growth of bacteria. This medication will not work for other types of eye infections."
Answered by AI
Is there a generic for AzaSite eye drops?
"There is no generic form of the antibiotic AzaSite currently available, though there are alternative brands that may be more affordable depending on your insurance coverage. Talk to your doctor about other options that may be available to you."
Answered by AI